Levine Tox Consulting

Executive Summary

Levine Tox Consulting is a specialized consulting firm based in Boston, MA, offering expertise in nonclinical drug development and forensic toxicology. Founded in 2012, the company supports a wide range of therapeutic modalities including small molecules, biologics (proteins and monoclonal antibodies), and biosimilars. Their services span all phases of nonclinical development, from preclinical safety assessment to regulatory submissions, as well as product liability and forensic toxicology investigations. By leveraging deep scientific knowledge and regulatory experience, Levine Tox Consulting helps clients navigate complex toxicology challenges, mitigate risks, and accelerate drug development timelines. The firm's boutique approach and focus on both innovation and litigation support position it as a trusted partner for biopharma companies, law firms, and regulatory agencies. Despite being a private consulting firm without disclosed financials, its reputation and niche expertise suggest steady demand, particularly as regulatory scrutiny and biosimilar development continue to rise.

Upcoming Catalysts (preview)

• Q3 2026Expansion into biosimilar safety consulting70% success
• Q4 2026Strategic partnership with CROs for nonclinical services50% success
• Q2 2026Publication of case studies in forensic toxicology60% success